Oral Treatment of Obesity by GLP-1 and Its Analogs
Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics
A forum for researchers, students and applicants in the field of cyclodextrin technology
Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics
The present Special Issue in Polymers welcomes contributions in the form of original research articles, preclinical investigations, or review articles
Cell migration plays a crucial role in the dynamic processes that guide tissue development, regeneration, and repair; yet, developing cell
δ‑Cyclodextrin (δ‑CD or delta-CD) is a unique, novel nine-membered cyclodextrin with a larger internal cavity than α-, β-, or γ-cyclodextrins,
Beren Therapeutics Announced FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C. Beren Therapeutics
The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the
Amorphous red phosphorus (ARP) has recently been identified as a zig-zag ladder polymer, yet its function beyond a low-cost phosphorus
The cochlea is the sensory organ responsible for hearing. Central to its sensory functions is the organ of Corti, a
Soy peptides (SPs) have been extensively studied with an emphasis on their immune-boosting effects and production-associated bitterness. This associated bitterness
The Materials Science and Engineering (MSE) Congress 2026 will be held from September 29 to October 1, 2026, in Darmstadt, Germany, as a